BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang ML, Liaw YF. Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses. Int J Mol Sci 2022;23:1552. [PMID: 35163476 DOI: 10.3390/ijms23031552] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu M, Huang L, Zhang S, Jiang L, Jin Y, Gu M, Liao J, Zhang J. Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression. Front Cell Infect Microbiol 2023;13. [DOI: 10.3389/fcimb.2023.1082390] [Reference Citation Analysis]
2 Hu M, Liao G, Wei S, Qian Z, Chen H, Xia M, Xie Q, Peng J. Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study. Infect Dis Ther 2023. [PMID: 36633817 DOI: 10.1007/s40121-022-00757-y] [Reference Citation Analysis]
3 Zeng Z, Liu R, Cao W, Yang L, Lin Y, Bi X, Jiang T, Deng W, Wang S, Lu H, Sun F, Shen G, Chang M, Lu Y, Wu S, Hao H, Xu M, Chen X, Hu L, Zhang L, Wan G, Xie Y, Li M. Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative. Front Immunol 2022;13:1113070. [PMID: 36685494 DOI: 10.3389/fimmu.2022.1113070] [Reference Citation Analysis]
4 Zeng Z, Hao H, Bi X, Lin Y, Yang L, Wang S, Shen G, Chang M, Jiang T, Deng W, Lu H, Sun F, Lu Y, Gao Y, Liu R, Xu M, Chen X, Hu L, Zhang L, Li M, Xie Y. Study on liver histopathology of chronic HBV infected patients with different normal ALT values. Front Immunol 2022;13:1069752. [PMID: 36483546 DOI: 10.3389/fimmu.2022.1069752] [Reference Citation Analysis]
5 Zheng J, Wang Z, Feng B. Hepatitis B functional cure and immune response. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1075916] [Reference Citation Analysis]
6 Liaw YF. Hepatitis B flare: the good, the bad and the ugly. Expert Rev Gastroenterol Hepatol 2022;16:1043-51. [PMID: 36476208 DOI: 10.1080/17474124.2022.2156338] [Reference Citation Analysis]
7 Yin GQ, Chen KP, Gu XC. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. World J Gastroenterol 2022; 28(40): 5784-5800 [DOI: 10.3748/wjg.v28.i40.5784] [Reference Citation Analysis]
8 Chang ML, Chien RN, Liaw YF. Robust antiviral responses in severe hepatitis flare persist after early retreatment cessation and lead toward hepatitis B surface antigen loss: A proof-of-concept study. Hepatol Res 2022;52:817-23. [PMID: 35716249 DOI: 10.1111/hepr.13804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chu J, Yang Y, Liu Y, Pei L, Zhou Y, Lu T, Zhang Y, Hu H, Li Y, Yang F, Lin S. Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares. Infect Dis Ther 2022. [PMID: 36151452 DOI: 10.1007/s40121-022-00695-9] [Reference Citation Analysis]
10 Su Y, Chang M, Chien R, Liaw Y. Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies. Viruses 2022;14:1858. [DOI: 10.3390/v14091858] [Reference Citation Analysis]
11 Liu J, Zhang D, Cao Y, Zhang H, Li J, Xu J, Yu L, Ye S, Yang L. Screening of crosstalk and pyroptosis-related genes linking periodontitis and osteoporosis based on bioinformatics and machine learning. Front Immunol 2022;13:955441. [DOI: 10.3389/fimmu.2022.955441] [Reference Citation Analysis]
12 Lee KC, Cheng JS, Chang ML, Chien RN, Liaw YF. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study. Hepatol Int 2022. [PMID: 35699864 DOI: 10.1007/s12072-022-10357-0] [Reference Citation Analysis]
13 Chang ML, Chen WT, Chan TM, Lin CY, Chang MY, Chen SC, Chien RN. Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to 28 Years. Front Immunol 2022;13:869018. [PMID: 35663951 DOI: 10.3389/fimmu.2022.869018] [Reference Citation Analysis]
14 Li M, Zhang L, Xie S, Sun F, Zeng Z, Deng W, Jiang T, Bi X, Lin Y, Yang L, Lu Y, Shen G, Liu R, Wu S, Chang M, Hu L, Dong J, Yi W, Xie Y. Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Front Immunol 2022;13:892031. [PMID: 35603222 DOI: 10.3389/fimmu.2022.892031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]